4//SEC Filing
Patel Sanjiv 4
Accession 0000950170-25-008451
CIK 0001812364other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 7:01 PM ET
Size
12.0 KB
Accession
0000950170-25-008451
Insider Transaction Report
Form 4
Patel Sanjiv
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-01-22$4.80/sh−125,000$600,000→ 324,548 total(indirect: By Trust) - Sale
Common Stock
2025-01-23$4.78/sh−125,000$597,500→ 199,548 total(indirect: By Trust) - Sale
Common Stock
2025-01-21$4.52/sh−125,000$565,000→ 449,548 total(indirect: By Trust)
Holdings
- 766,130
Common Stock
- 687,355(indirect: By Trust)
Common Stock
Footnotes (7)
- [F1]These shares were sold by the Patel Family Irrevocable Trust of 2019 (the "Trust") pursuant to a Rule 10b5-1 trading plan adopted by the Trust on August 7, 2024.
- [F2]This transaction was executed in multiple trades at prices ranging from $4.35 to $4.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]These shares are held in the Trust for the benefit of the reporting person's family members. An independent trustee is trustee of the Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F4]This transaction was executed in multiple trades at prices ranging from $4.65 to $4.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F5]This transaction was executed in multiple trades at prices ranging from $4.62 to $4.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F6]Includes 762,360 shares underlying restricted stock units.
- [F7]These shares are held in an irrevocable trust for the benefit of the reporting person's family members. An independent trustee is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Relay Therapeutics, Inc.
CIK 0001812364
Entity typeother
Related Parties
1- filerCIK 0001816210
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 7:01 PM ET
- Size
- 12.0 KB